All Pharma News
price-trendAsk Us
Arrakis Therapeutics reduces headcount by 20%

Arrakis Therapeutics reduces headcount by 20%
Kyle LaHucik ENDPTS
01 Mar 2024
Share Share
Arrakis Therapeutics to Present at Jefferies Healthcare Conference

Arrakis Therapeutics to Present at Jefferies Healthcare Conference
BUSINESSWIRE
01 Jun 2022
Share Share
Arrakis Therapeutics to Participate in Upcoming May Investor Conferences

Arrakis Therapeutics to Participate in Upcoming May Investor Conferences
BUSINESSWIRE
10 May 2022
Share Share
Arrakis Therapeutics to Participate in Upcoming Investor Conferences

Arrakis Therapeutics to Participate in Upcoming Investor Conferences
BUSINESSWIRE
31 Mar 2022
Share Share
Arrakis Tx to Present at Guggenheim Healthcare Talks Oncology Conference

Arrakis Tx to Present at Guggenheim Healthcare Talks Oncology Conference
BUSINESSWIRE
08 Feb 2022
Share Share
Amgen partners with Arrakis to develop drugs aimed at RNA

Amgen partners with Arrakis to develop drugs aimed at RNA
N. Pagliarulo BIOPHARMADIVE
12 Jan 2022
Share Share
Arrakis Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Arrakis Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
BUSINESSWIRE
10 Jan 2022
Share Share
Big Pharma can`t get enough from drugging RNA

Big Pharma can`t get enough from drugging RNA
Nicole DeFeudis ENDPTS
29 Sep 2021
Share Share
Roche’s James Sabry zeroes in on a new pathway and he’s paying $135M

Roche’s James Sabry zeroes in on a new pathway and he’s paying $135M
John Carroll ENDPTS
19 May 2020
Share Share